» Articles » PMID: 30587577

Dephosphorylation of Human Dopamine Transporter at Threonine 48 by Protein Phosphatase PP1/2A Up-regulates Transport Velocity

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2018 Dec 28
PMID 30587577
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Several protein kinases, including protein kinase C, Ca/calmodulin-dependent protein kinase II, and extracellular signal-regulated kinase, play key roles in the regulation of dopamine transporter (DAT) functions. These functions include surface expression, internalization, and forward and reverse transport, with phosphorylation sites for these kinases being linked to distinct regions of the DAT N terminus. Protein phosphatases (PPs) also regulate DAT activity, but the specific residues associated with their activities have not yet been elucidated. In this study, using co-immunoprecipitation followed by MS and immunoblotting analyses, we demonstrate the association of DAT with PP1 and PP2A in the mouse brain and heterologous cell systems. By applying MS in conjunction with a metabolic labeling method, we defined a PP1/2A-sensitive phosphorylation site at Thr-48 in human DAT, a residue that has not been previously reported to be involved in DAT phosphorylation. Site-directed mutagenesis of Thr-48 to Ala (T48A) to prevent phosphorylation enhanced dopamine transport kinetics, supporting a role for this residue in regulating DAT activity. Moreover, T48A-DAT displayed increased palmitoylation, suggesting that phosphorylation/dephosphorylation at this site has an additional regulatory role and reinforcing a previously reported reciprocal relationship between C-terminal palmitoylation and N-terminal phosphorylation.

Citing Articles

Dopamine transporter membrane mobility is bidirectionally regulated by phosphorylation and palmitoylation.

Shetty M, Bolland D, Morrell J, Grove B, Foster J, Vaughan R Curr Res Physiol. 2023; 6:100106.

PMID: 38107792 PMC: 10724222. DOI: 10.1016/j.crphys.2023.100106.


Evaluation and Validation of Commercially Available Dopamine Transporter Antibodies.

Russo E, Zovko L, Nazari R, Steenland H, Ramsey A, Salahpour A eNeuro. 2023; 10(5).

PMID: 37142435 PMC: 10162361. DOI: 10.1523/ENEURO.0341-22.2023.


Overview of the structure and function of the dopamine transporter and its protein interactions.

Nepal B, Das S, Reith M, Kortagere S Front Physiol. 2023; 14:1150355.

PMID: 36935752 PMC: 10020207. DOI: 10.3389/fphys.2023.1150355.


A Practical and Analytical Comparative Study of Gel-Based Top-Down and Gel-Free Bottom-Up Proteomics Including Unbiased Proteoform Detection.

Ercan H, Resch U, Hsu F, Mitulovic G, Bileck A, Gerner C Cells. 2023; 12(5).

PMID: 36899884 PMC: 10000902. DOI: 10.3390/cells12050747.


Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5.

Ercan H, Schrottmaier W, Pirabe A, Schmuckenschlager A, Pereyra D, Santol J Front Cardiovasc Med. 2021; 8:779073.

PMID: 34859078 PMC: 8632253. DOI: 10.3389/fcvm.2021.779073.


References
1.
Foster J, Vaughan R . Palmitoylation controls dopamine transporter kinetics, degradation, and protein kinase C-dependent regulation. J Biol Chem. 2010; 286(7):5175-86. PMC: 3037630. DOI: 10.1074/jbc.M110.187872. View

2.
Zhuang X, Masson J, Gingrich J, Rayport S, Hen R . Targeted gene expression in dopamine and serotonin neurons of the mouse brain. J Neurosci Methods. 2005; 143(1):27-32. DOI: 10.1016/j.jneumeth.2004.09.020. View

3.
Vaughan R, Foster J . Mechanisms of dopamine transporter regulation in normal and disease states. Trends Pharmacol Sci. 2013; 34(9):489-96. PMC: 3831354. DOI: 10.1016/j.tips.2013.07.005. View

4.
Foster J, Pananusorn B, Vaughan R . Dopamine transporters are phosphorylated on N-terminal serines in rat striatum. J Biol Chem. 2002; 277(28):25178-86. DOI: 10.1074/jbc.M200294200. View

5.
Sung U, Jennings J, Link A, Blakely R . Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins. Biochem Biophys Res Commun. 2005; 333(3):671-8. DOI: 10.1016/j.bbrc.2005.05.165. View